Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019
Go back to Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 66.72 -0.23 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.95 | 52 Week High | $5.17 | |||
| Open | $66.26 | 52 Week Low | $0.94 | |||
| Day High | $68.48 | P/E | N/A | |||
| Day Low | $65.50 | EPS | $0.00 | |||
| Volume | 1,223,982 | |||||
